
Bone Marrow Can Harbor HIV-Infected Cells
Antiviral drugs have reduced
AIDS to more of chronic
disease rather than a death
sentence, but why is the
disease so hard to cure? New
research shows that bone
marrow, previously thought
... > full story

HIV Vaccine Strategy Expands Immune Responses
Researchers have announced
an HIV vaccination strategy
that has been shown to
expand the breadth and depth
of immune responses in
rhesus monkeys. Rhesus
... > full story

Southern African Genomes Sequenced: Benefits for Human Health Expected
Human genomes from Southern
African Bushmen and a Bantu
individual, Archbishop Tutu,
have been sequenced by
scientists seeking a greater
... > full story

3-D Structure of Bullet-Shaped Virus With Potential to Fight Cancer, HIV Revealed
A recent study demonstrates
that with advanced imaging
technique, the vesicular
stomatitis virus can be
modified to serve as an
... > full story
Browse News Stories
1 to 10 of 2,070 stories (320 over past year)
view headlines only
-
How to Fortify the Immunity of HIV Patients
March 9, 2010 New findings may soon lead to an expansion of the drug arsenal used to fight ... > full story -
Hepatitis B and C Remain Public Health Issue -- Up to 5.3 Million Americans Infected
March 4, 2010 A recent report confirmed that 3.5 to 5.3 million people (1-2 percent of the US population) have chronic hepatitis B virus or hepatitis C virus infections. Despite efforts by federal, state and local ... > full story -
Pneumococcal Vaccine Offers Protection to HIV-Infected African Adults in Clinical Trial
March 3, 2010 A clinical trial of a vaccine against a major cause of pneumonia and meningitis has shown that it can prevent three out of four cases of re-infection in HIV-infected adults in Africa. The trials, ... > full story -
HIV and Noncommunicable Diseases Hinder the Progress of Poor Countries' Millennium Development Goals
March 2, 2010 Problems controlling common diseases like HIV, heart disease and diabetes in poor countries could be hindering efforts to meet the world’s key child health and tuberculosis goals, a new study ... > full story -
Gene-Based Stem Cell Therapy Specifically Removes Cell Receptor That Attracts HIV
February 28, 2010 Researchers have successfully removed CCR5 -- a cell receptor to which HIV-1 binds for infection but which the human body does not need -- from human cells. Individuals who naturally lack the CCR5 ... > full story -
HIV Drug That Protects a Fetus Should Be Avoided for One Year After Childbirth, Researchers Say
February 28, 2010 A new study found that while nevirapine works well to prevent mother-to-child HIV transmission, a single dose of nevirapine in infected pregnant women can trigger resistance to some forms of the ... > full story -
Single-Dose HIV DNA Vaccine Induces Long-Lasting Immune Response in Monkeys
February 26, 2010 For the first time researchers from the U.S. and abroad have shown a single-dose HIV DNA vaccine can induce a long-lasting HIV-specific immune response in nonhuman primates, a discovery that could ... > full story -
Innate Immune Mechanisms Can Control Disease Progression in HIV-Positive Patients
February 26, 2010 A new study by researchers in Spain shows that dendritic cells in HIV positive patients who spontaneously control the infection produce high levels of alpha-defensins. Results show that cells from ... > full story -
Combined Drug Therapy to Treat TB and HIV Significantly Improves Survival
February 25, 2010 Initiating antiretroviral therapy (ART) during tuberculosis therapy significantly reduced mortality rates by 56 percent in a randomized clinical trial of 642 patients co-infected with HIV and ... > full story -
HIV Drug Resistance Lasts About One Year in Women Treated With Nevirapine to Prevent Infant Infection, Study Suggests
February 25, 2010 A new study confirms that a single dose of nevirapine (sdNVP) can lead to HIV treatment failure in women who receive the drug to prevent transmission of the AIDS virus to their infants. However, the ... > full story
Search ScienceDaily
Number of stories in archives: 82,619

